Literature DB >> 19193000

Management of emergent psychiatric symptoms during smoking cessation.

Henri-Jean Aubin1.   

Abstract

BACKGROUND: Tobacco smoking is a major risk factor for cardiovascular disease, respiratory disease and cancer and, for current smokers, smoking cessation is one of the most effective therapeutic interventions for reducing the risk of all-cause morbidity and mortality. However, smoking cessation causes nicotine withdrawal syndrome, a condition with symptoms that overlap those of major depression and anxiety disorders. SCOPE: The objective of this review was to examine the evidence that smoking cessation may be associated with new onset of psychiatric illness, particularly in individuals with no history of psychiatric disease, and to provide recommendations for the management of emergent psychiatric symptoms in smokers attempting cessation. Relevant articles were obtained from a MEDLINE search (articles indexed up to, and including, October 2008, with no historical date limit), and citation review of selected primary and review articles.
FINDINGS: There is evidence that smoking cessation can result in new onset of major depressive disorder, even in individuals with no history of depression. It has also been suggested that nicotine may be used as a form of self-medication for depression, and that smoking cessation can reveal a previously undiagnosed condition. There is little evidence of an association between smoking cessation and increased risk for other types of psychiatric illness. The management of emergent psychiatric symptoms in smokers attempting abstinence is discussed.
CONCLUSION: The overall health benefits of quitting smoking undoubtedly outweigh any potential side-effects associated with nicotine withdrawal. However, a well-managed quit attempt must plan for the emergence of nicotine withdrawal, monitor for symptoms of depression and psychiatric disease, and manage these conditions appropriately should they present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19193000     DOI: 10.1185/03007990802707600

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  11 in total

1.  Personality disorders and the 3-year course of alcohol, drug, and nicotine use disorders.

Authors:  Deborah Hasin; Miriam C Fenton; Andrew Skodol; Robert Krueger; Katherine Keyes; Timothy Geier; Eliana Greenstein; Carlos Blanco; Bridget Grant
Journal:  Arch Gen Psychiatry       Date:  2011-11

2.  Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.

Authors:  Daniel Tranel; Ashton McNutt; Antoine Bechara
Journal:  Cogn Behav Neurol       Date:  2012-03       Impact factor: 1.600

3.  Improved clinical outcomes among persons with HIV who quit smoking.

Authors:  Su Fen Lubitz; Alex Flitter; Rebecca L Ashare; Morgan Thompson; Frank Leone; Robert Gross; Robert Schnoll
Journal:  AIDS Care       Date:  2019-12-17

4.  Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial.

Authors:  Miles McFall; Andrew J Saxon; Carol A Malte; Bruce Chow; Sara Bailey; Dewleen G Baker; Jean C Beckham; Kathy D Boardman; Timothy P Carmody; Anne M Joseph; Mark W Smith; Mei-Chiung Shih; Ying Lu; Mark Holodniy; Philip W Lavori
Journal:  JAMA       Date:  2010-12-08       Impact factor: 56.272

Review 5.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

6.  Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.

Authors:  Li-Tzy Wu; Kenneth R Gersing; Marvin S Swartz; Bruce Burchett; Ting-Kai Li; Dan G Blazer
Journal:  J Psychiatr Res       Date:  2013-01-19       Impact factor: 4.791

7.  Effects of time-varying changes in tobacco and alcohol use on depressive symptoms following pharmaco-behavioral treatment for smoking and heavy drinking.

Authors:  William V Lechner; Natasha K Sidhu; Patricia A Cioe; Christopher W Kahler
Journal:  Drug Alcohol Depend       Date:  2018-11-06       Impact factor: 4.492

Review 8.  A consensus statement for safety monitoring guidelines of treatments for major depressive disorder.

Authors:  Seetal Dodd; Gin S Malhi; John Tiller; Isaac Schweitzer; Ian Hickie; Jon Paul Khoo; Darryl L Bassett; Bill Lyndon; Philip B Mitchell; Gordon Parker; Paul B Fitzgerald; Marc Udina; Ajeet Singh; Steven Moylan; Francesco Giorlando; Carolyn Doughty; Christopher G Davey; Michael Theodoros; Michael Berk
Journal:  Aust N Z J Psychiatry       Date:  2011-09       Impact factor: 5.744

9.  Depression and Smoking Cessation: Evidence from a Smoking Cessation Clinic with 1-Year Follow-Up.

Authors:  Lenka Stepankova; Eva Kralikova; Kamila Zvolska; Alexandra Pankova; Petra Ovesna; Milan Blaha; Leonie S Brose
Journal:  Ann Behav Med       Date:  2017-06

10.  Health behaviors in major chronic diseases patients: trends and regional variations analysis, 2008-2017, Korea.

Authors:  Young-Jee Jeon; Jeehee Pyo; Young-Kwon Park; Minsu Ock
Journal:  BMC Public Health       Date:  2020-11-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.